Erowid.org: Erowid Reference 7779 : ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist : Acuña-Castillo, C. Scorza, C. Reyes-Parada, M Cassels, BK Huidobro-Toro, JP

Erowid References Database

Acuña-Castillo, C. Scorza, C. Reyes-Parada, M Cassels, BK Huidobro-Toro, JP. “ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist”. Life Sciences. 2000 Jun 06;67:3241-7. <a name="ref">Acuña-Castillo, C. Scorza, C. Reyes-Parada, M Cassels, BK Huidobro-Toro, JP.</a> <a href="/references/7779">"ALEPH-2, a suspected anxiolytic and putative hallucinogenic phenylisopropylamine derivative, is a 5-HT2a and 5-HT2c receptor agonist"</a> <i>Life Sciences</i>. 2000 Jun 06;67:3241-7.
Text Abstract (this page) Full Text - English (private) Show Articles by Acuña-Castillo C. Scorza C. Reyes-Parada M Cassels BK Huidobro-Toro Article IDs Erowid RefID: 7779 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract To assess the pharmacodynamic profile of ALEPH-2, a phenylisopropylamine derivative with alleged anxiolytic and hallucinogenic properties, Xenopus laevis oocytes were microinjected with either of the rat cRNA for the 5-HT2A or the 5-HT2C receptor. Concentration-response curves were obtained following the exposure of the oocytes to varying concentrations of either ALEPH-2 or 5-hydroxytryptamine (5-HT) for 10 s. ALEPH-2 is a partial agonist on the 5-HT2A receptor with a similar potency to 5-HT. In contrast, ALEPH-2 is a full 5-HT2C receptor agonist and is about 15-fold less potent than 5-HT. Pre-application of 1 mM ritanserin antagonized the responses induced by 5-HT and ALEPH-2 to the same extent; however, the 5-HT2A receptor is more sensitive to ritanserin blockade than the 5-HT2C receptor.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]